Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000318306-07-000001
Filing Date
2007-01-08
Accepted
2007-01-08 12:00:27
Documents
1
Period of Report
2007-01-04

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 2154
  Complete submission text file 0000318306-07-000001.txt   4216
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Issuer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ACCESS PHARMACEUTICALS, INC. 2600 STEMMONS FREEWAY, SUITE 176 DALLAS TX 75207
Business Address (214) 905-5100
SEILER STEPHEN R (Reporting) CIK: 0001193365 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-15771 | Film No.: 07516565